OPT-MVAC partner country updates

Across the OPT-MVAC consortium, partner countries are undertaking research activities to better understand malaria vaccine coverage, identify barriers to uptake and inform strategies to optimise vaccine delivery. Here are some of the latest developments across our network.
  • Following an earlier coverage study undertaken as part of the Gavi-funded SIRI project, Benin is preparing a follow-up survey, fully funded by OPT-MVAC, focusing primarily on fourth-dose (D4) coverage. Building on the first study, which assessed coverage of the first three vaccine doses (D1–D3), the follow-up survey will assess D4 uptake following its postponement for some children to coincide with the 2026 high-transmission season.
  • Burkina Faso has completed its malaria vaccine coverage survey as part of a broader national immunisation survey. A qualitative study is being planned to explore barriers to vaccination and opportunities to improve coverage.
  • Cameroon has obtained ethical approval and is preparing a coverage survey assessing uptake of both the primary three-dose series and D4, which it aims to launch before the end of 2026. This will be complemented by a qualitative study exploring barriers to vaccine uptake.
  • The country team in Chad is refining its research protocol with technical support from the OPT-MVAC scientific team.
  • The country team in Côte d’Ivoire is refining its research protocol with technical support from OPT-MVAC.
  • The Gambia is planning to introduce malaria vaccines in 2028.
  • In Ghana, one of the first countries to introduce the malaria vaccine, discussions are underway to explore the feasibility of testing a seasonal intensification strategy to improve coverage.
  • Guinea launched its malaria vaccine coverage survey on 10 November 2026 under the Gavi-funded SIRI project. OPT-MVAC colleagues participated in the training, piloting and launch activities.
  • The country team in Guinea-Bissau is progressing with preparatory activities for a malaria vaccine coverage survey expected in 2027, in alignment with national vaccine introduction and implementation timelines.
  • The country team in Mali is refining its research protocol with technical support from OPT-MVAC. The coverage survey is planned for January 2027, following completion of the first seasonal fourth-dose delivery period under the country’s hybrid vaccination strategy.
  • Niger has obtained ethical approval and is preparing a coverage survey assessing uptake of both the primary three-dose series and D4. This will be complemented by a qualitative study exploring barriers to vaccine uptake.
  • The country team in Nigeria is progressing with preparatory activities for a malaria vaccine coverage survey expected in 2027, in alignment with national vaccine introduction and implementation timelines.
  • Senegal has submitted its application to Gavi and is awaiting confirmation of approval for malaria vaccine introduction.
  • The country team in Togo is advancing the development of its research protocol with technical support from OPT-MVAC. A coverage survey focusing on the primary vaccine doses is planned for around March 2027.

 

Share this article:

Please fill in the details below to complete your subscription